Wolverine Trading’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.35M Buy
2,700
+1,000
+59% +$437K ﹤0.01% 2583
2025
Q2
$528K Sell
1,700
-100
-6% -$30K ﹤0.01% 2893
2025
Q1
$562K Sell
1,800
-300
-14% -$101K ﹤0.01% 2842
2024
Q4
$700K Sell
2,100
-1,300
-38% -$441K ﹤0.01% 3034
2024
Q3
$1.13M Buy
3,400
+2,500
+278% +$950K ﹤0.01% 2233
2024
Q2
$371K Sell
900
-4,400
-83% -$1.74M ﹤0.01% 3139
2024
Q1
$2.14M Sell
5,300
-1,000
-16% -$352K ﹤0.01% 1564
2023
Q4
$1.93M Buy
+6,300
New +$1.7M ﹤0.01% 1741
2022
Q1
Sell
-4,300
Closed -$942K 6029
2021
Q4
$942K Buy
4,300
+3,200
+291% +$670K ﹤0.01% 2693
2021
Q3
$206K Buy
+1,100
New +$201K ﹤0.01% 5298
2020
Q4
Sell
-3,900
Closed -$434K 5203
2020
Q3
$434K Buy
+3,900
New +$451K ﹤0.01% 2978
2020
Q2
Sell
-6,200
Closed -$465K 4960
2020
Q1
$465K Buy
+6,200
New +$538K ﹤0.01% 2735
2019
Q4
Sell
-17,300
Closed -$1.44M 4980
2019
Q3
$1.44M Buy
17,300
+8,200
+90% +$620K ﹤0.01% 1679
2019
Q2
$595K Sell
9,100
-44,600
-83% -$2.57M ﹤0.01% 2534
2019
Q1
$3.17M Buy
53,700
+42,200
+367% +$2.52M 0.01% 1173
2018
Q4
$596K Sell
11,500
-14,000
-55% -$769K ﹤0.01% 2471
2018
Q3
$1.53M Buy
+25,500
New +$1.39M ﹤0.01% 1918

Other funds holding MEDP

Wolverine Trading's MEDP Position: Q4 2024 in Review

Wolverine Trading sold out of Medpace (MEDP) in Q4 2024, closing a stake of 790 shares — an estimated $268K sold.

Wolverine Trading first reported a position in MEDP in Q1 2018 and held it in 12 quarters. The position peaked at $1.53M in Q3 2018. 592 funds tracked by Wall St. Rank hold MEDP as of Q4 2024.

  • Wolverine Trading reported no remaining Medpace position as of Q4 2024 after selling out during the quarter.
  • Wolverine Trading sold 790 Medpace shares in Q4 2024, an estimated $268K.
  • Wolverine Trading first reported a position in Medpace in Q1 2018 and held it in 12 quarters.
  • Wolverine Trading's Medpace position peaked at $1.53M in Q3 2018.
  • 592 funds tracked by Wall St. Rank held Medpace as of Q4 2024.

Based on Wolverine Trading's 13F filing for Q4 2024, filed 14 Feb 2025.